What serious adverse reactions happened during this study?
The most common serious adverse reaction during the study was sudden kidney
damage.
The table below shows the serious adverse reactions that happened in at least
4 participants during this study. There were other serious adverse reactions that
happened, but those happened in fewer participants.
Most common serious adverse reactions during this study
Dapagliflozin Placebo
Serious adverse (out of 2,149 (out of 2,149
reaction participants) participants)
Sudden kidney damage 0.5% (11) 0.3% (7)
Urinary tract infection 0.2% (4) 0.2% (5)
Decreased blood sugar 0.1% (2) 0.2% (5)
Stroke 0.1% (2) 0.1% (2)
None of the participants who took the placebo died due to serious adverse
reactions. There were 0.1% of participants who took dapagliflozin who died due
to serious adverse reactions. This was 2 out of 2,149 participants. These adverse
reactions were:
• heart attack
• stroke
What adverse reactions happened during this study?
Because the researchers did not collect information about all medical problems
in the study, they could not calculate the most common adverse reactions
overall.
10 | Clinical Study Results